{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:26:04Z","timestamp":1788456364191,"version":"build-2803163510"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ejim.2017.10.016","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T01:47:25Z","timestamp":1509500845000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Liver disease and heart failure: Back and forth"],"prefix":"10.1016","volume":"48","author":[{"given":"Michele","family":"Correale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Tricarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Laonigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9610-7408","authenticated-orcid":false,"given":"Natale Daniele","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2017.10.016_bb0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/eurjhf\/hfp037","article-title":"Alcool abuse and hear failure","volume":"11","author":"Laonigro","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2017.10.016_bb0010","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver","volume":"34","author":"Moller","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.10.016_bb0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hep.26610","article-title":"Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease","volume":"59","author":"Pacifico","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.10.016_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4254\/wjh.v6.i1.41","article-title":"Hepato-cardiac disorders","volume":"6","author":"Fouad","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0025","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.15252\/emmm.201404749","article-title":"Heart over mind: metabolic control of white adipose tissue and liver","volume":"6","author":"Nakamura","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijcard.2011.07.056","article-title":"Analysis of liver metabolism in a rat model of heart failure","volume":"161","author":"Kato","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0035","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/emmm.201302852","article-title":"Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy","volume":"6","author":"Magida","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2362.2011.02573.x","article-title":"Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance","volume":"42","author":"Poelzl","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2017.10.016_bb0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijcard.2012.05.003","article-title":"Congestive hepatophaty and hypoxic hepatitis in heart failure: a cardiologist's point of view","volume":"166","author":"Kavouliuniene","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF01707667","article-title":"Functional deterioration of the liver by elevated inferior vena cava pressure: a proposed upper safety limit of pressure for maintaining liver viability in dogs","volume":"20","author":"Higashiyama","year":"1994","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.echo.2015.09.012","article-title":"Echocardiographic correlates of abnormal liver tests in patients with exacerbation of chronic heart failure","volume":"29","author":"Styczynski","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ejim.2017.10.016_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17140\/LROJ-1-101","article-title":"Cardiac hepatopathy: a review of liver dysfunction in heart failure","volume":"1","author":"Shah","year":"2015","journal-title":"Liver Res Open J"},{"key":"10.1016\/j.ejim.2017.10.016_bb0065","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1590\/S0066-782X2007000500015","article-title":"Clinical evaluation and hepatic laboratory assessment in individuals with congestive heart failure","volume":"88","author":"Vasconcelos","year":"2007","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0070","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9149(02)02886-2","article-title":"Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation","volume":"90","author":"Lau","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0075","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/archinte.1987.00370070041006","article-title":"Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics","volume":"147","author":"Kubo","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0080","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1089-3261(02)00056-9","article-title":"The liver in heart failure","volume":"6","author":"Giallourakis","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ejim.2017.10.016_bb0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0031-1284434","article-title":"Liver abnormalities in cardiac diseases and heart failure","volume":"20","author":"Alvarez","year":"2011","journal-title":"Int J Angiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"Van Deursen","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.ejim.2017.10.016_bb0095","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ejhf.532","article-title":"Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study","volume":"18","author":"Biegus","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2017.10.016_bb0100","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/gut.52.10.1511","article-title":"Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease","volume":"52","author":"Henriksen","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2017.10.016_bb0105","first-page":"181","article-title":"Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients","volume":"56","author":"Radvan","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejim.2017.10.016_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17140\/LROJ-1-101","article-title":"Cardiac hepatopathy: a review of liver dysfunction in heart failure","volume":"1","author":"Shah","year":"2015","journal-title":"Liver Res Open J"},{"key":"10.1016\/j.ejim.2017.10.016_bb0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/AC.68.2.2967276","article-title":"Subclinical diastolic dysfunction in children with Wilson's disease assessed by tissue Doppler echocardiography: a possible early predictor of cardiac involvement","volume":"68","author":"Elkiran","year":"2013","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3748\/wjg.v13.i4.647","article-title":"Cytomegalovirus hepatitis and myopericarditis","volume":"13","author":"Zubiaurre","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0125","first-page":"145","article-title":"Iron overload disease: recent findings","volume":"19","author":"Licata","year":"2004","journal-title":"Ann Ital Med Int"},{"key":"10.1016\/j.ejim.2017.10.016_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.11604\/pamj.2016.24.209.7980","article-title":"Hepatic sarcoidosis: a case series","volume":"24","author":"Ennaifer","year":"2016","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.ejim.2017.10.016_bb0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: a comprehensive review","volume":"49","author":"Judson","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2017.10.016_bb0140","first-page":"S21","article-title":"Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD)","volume":"7","author":"Matsukuma","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0145","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbmt.2005.07.002","article-title":"Cardiac manifestations of graft-versus-host disease","volume":"11","author":"Rackley","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ejim.2017.10.016_bb0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11894-009-0008-4","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk","volume":"11","author":"Misra","year":"2009","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.ejim.2017.10.016_bb0155","first-page":"244","article-title":"Liver complications in patients with congestive heart failure","volume":"9","author":"Giallourakis","year":"2013","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0163-7258(01)00124-3","article-title":"The hyperdynamic circulation in cirrhosis: an overview","volume":"89","author":"Blendis","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ejim.2017.10.016_bb0165","first-page":"505","article-title":"Circulatory abnormalities in cirrhosis with focus on neurohumoral aspects","volume":"17","author":"M\u00f8ller","year":"1997","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/heart.87.1.9","article-title":"Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease","volume":"87","author":"M\u00f8ller","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2017.10.016_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1530-0277.1995.tb01479.x","article-title":"Vasodilatory state of decompensated cirrhosis: relation to hepatic dysfunction, ascites, and vasoactive substances","volume":"19","author":"Friedman","year":"1995","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ejim.2017.10.016_bb0180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/cs0970259","article-title":"Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis","volume":"97","author":"Wong","year":"1999","journal-title":"Clin Sci"},{"key":"10.1016\/j.ejim.2017.10.016_bb0185","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1440-1746.1999.01920.x","article-title":"Cardiopulmonary dysfunction in cirrhosis","volume":"14","author":"Liu","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0190","first-page":"1175","article-title":"Impaired left ventricular function in alcoholic cirrhosis with ascites","volume":"89","author":"Limas","year":"1977","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0195","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0140-6736(93)90879-L","article-title":"Q-T prolongation and sudden cardiac death in patients with alcoholic liver disease","volume":"341","author":"Day","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.10.016_bb0200","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hep.510230529","article-title":"Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease","volume":"23","author":"Mohamed","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.10.016_bb0205","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1161\/CIRCULATIONAHA.112.150656","article-title":"Cardiokines: recent progress in elucidating the cardiac secretome","volume":"126","author":"Shimano","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.10.016_bb0210","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.mco.0000222103.29009.70","article-title":"Angiotensin II as candidate of cardiac cachexia","volume":"9","author":"Delafontaine","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.ejim.2017.10.016_bb0215","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1161\/CIRCULATIONAHA.112.150656","article-title":"Cardiokines: recent progress in elucidating the cardiac secretome","volume":"126","author":"Shimano","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.10.016_bb0220","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cell.2012.03.029","article-title":"A cardiac microRNA governs systemic energy homeostasis by regulation of MED13","volume":"149","author":"Grueter","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejim.2017.10.016_bb0225","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.15252\/emmm.201404218","article-title":"MED13 dependent signaling from the heart confers leanness by enhancing metabolism in adipose tissue and liver","volume":"6","author":"Baskin","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0230","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/emmm.201303800","article-title":"The heart-liver metabolic axis: defective communication exacerbates disease","volume":"6","author":"Baskin","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0235","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cjca.2015.05.019","article-title":"From heart failure to highly unsaturated fatty acid deficiency and vice versa: bidirectional heart and liver interactions","volume":"32","author":"Alter","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-86-2-183","article-title":"Aspirin hepatotoxicity and disseminated intravascular coagulation","volume":"86","author":"Sbarbaro","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0245","first-page":"277","article-title":"Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting","volume":"58","author":"Anselmino","year":"2010","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0250","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003495-200565040-00003","article-title":"Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke","volume":"65","author":"Weinberger","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.ejim.2017.10.016_bb0255","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8068276","article-title":"Clopidogrel-induced severe hepatitis: a case report and literature review","volume":"2016","author":"Keshmiri","year":"2016","journal-title":"Case Reports Hepatol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0260","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00228-011-1126-0","article-title":"Amiodarone-induced acute hepatotoxicity","volume":"68","author":"Rao","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0265","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.freeradbiomed.2011.09.004","article-title":"Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration","volume":"51","author":"Serviddio","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0270","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/15748863113089990031","article-title":"Severe toxic hepatitis associated with dronedarone","volume":"8","author":"Jahn","year":"2013","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.ejim.2017.10.016_bb0275","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4103\/1319-3767.118137","article-title":"Propafenone hepatotoxicity: report of a new case and review of the literature","volume":"19","author":"Younan","year":"2013","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0280","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/2249-4863.141635","article-title":"Losartan-induced ischemic hepatocellular hepatotoxicity: a case report and literature review","volume":"3","author":"Al-Halawani","year":"2014","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.ejim.2017.10.016_bb0285","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.5858\/2003-127-1493-RH","article-title":"Ramipril-associated hepatotoxicity","volume":"127","author":"Yeung","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0290","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2146\/ajhp130149","article-title":"Probable drug-induced liver injury associated with aliskiren: case report and review of adverse event reports from pharmacovigilance databases","volume":"71","author":"Crepin","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejim.2017.10.016_bb0295","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hep.1840090126","article-title":"Metoprolol-induced hepatitis: Is the rate of oxidation related to drug-induced hepatotoxicity?","volume":"9","author":"Lennard","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.10.016_bb0300","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/ageing\/afh148","article-title":"Hydrochlorothiazide induced hepato-cholestatic liver injury","volume":"33","author":"Arinzon","year":"2004","journal-title":"Age Ageing"},{"key":"10.1016\/j.ejim.2017.10.016_bb0305","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.freeradbiomed.2004.08.020","article-title":"Ethacrynic-acid-induced glutathione depletion and oxidative stress in normal and Mrp2-deficient rat liver","volume":"37","author":"Ji","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0310","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1183\/09031936.00094409","article-title":"Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy?","volume":"34","author":"Hoeper","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2017.10.016_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087548","article-title":"Evaluation of the endothelin receptor antagonistsambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes","volume":"9","author":"Lepist","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2017.10.016_bb0320","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.1986.00360210235037","article-title":"Cholestatic hepatic injury related to warfarin exposure","volume":"146","author":"Adler","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0325","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2146\/ajhp080311","article-title":"Probable enoxaparin-induced hepatotoxicity","volume":"66","author":"Baker","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejim.2017.10.016_bb0330","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40264-015-0317-5","article-title":"Hepatotoxicity of new oral anticoagulants (NOACs)","volume":"38","author":"Liakoni","year":"2015","journal-title":"Drug Saf"},{"key":"10.1016\/j.ejim.2017.10.016_bb0335","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4065\/mcp.2009.0365","article-title":"Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma","volume":"85","author":"Calderon","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejim.2017.10.016_bb0340","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cld.2007.06.010","article-title":"Lipid lowering agents that cause drug induced hepatotoxicity","volume":"11","author":"Bhardwaj","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ejim.2017.10.016_bb0345","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1592\/phco.24.6.584.34738","article-title":"Statins and liver toxicity: a meta-analysis","volume":"24","author":"deDenus","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejim.2017.10.016_bb0350","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bjid.2013.05.014","article-title":"Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: case report and literature review","volume":"18","author":"Zhao","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ejim.2017.10.016_bb0355","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2353\/ajpath.2007.060906","article-title":"Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice","volume":"171","author":"Reifenberg","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0360","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1536\/ihj.46.1033","article-title":"Influence of interferon therapy on signal-averaged and ambulatory electrocardiograms in patients with chronic active hepatitis","volume":"46","author":"Hiramatsu","year":"2005","journal-title":"Int Heart J"},{"key":"10.1016\/j.ejim.2017.10.016_bb0365","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.athoracsur.2009.09.084","article-title":"Peginterferon alpha-2b and acute allograft failure in a heart transplant recipient","volume":"89","author":"Wang","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejim.2017.10.016_bb0370","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.transproceed.2010.09.096","article-title":"Outcome of treatment with pegylated interferon and ribavirin in heart transplant recipients with chronic hepatitis C","volume":"43","author":"Durante-Mangoni","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ejim.2017.10.016_bb0375","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-230X-11-30","article-title":"Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report","volume":"11","author":"Popescu","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0380","first-page":"238","article-title":"Treatment of hepatitis C virus infection and associated vascular complications: a literature review","volume":"39","author":"Karbasi-Afshai","year":"2014","journal-title":"Iran J Med Sci"},{"key":"10.1016\/j.ejim.2017.10.016_bb0385","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00380-004-0780-x","article-title":"Effects of interferon-alpha therapy on cardiac function in patients with chronic hepatitis B infection","volume":"19","author":"Erol","year":"2004","journal-title":"Heart Vessels"},{"key":"10.1016\/j.ejim.2017.10.016_bb0390","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1053\/j.gastro.2015.07.051","article-title":"Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge","volume":"149","author":"Renet","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2017.10.016_bb0395","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.chest.2015.09.018","article-title":"Severe pulmonary arterial hypertension in patients treated for hepatitis C with sofosbuvir","volume":"149","author":"Renard","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2017.10.016_bb0400","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/imj.12222","article-title":"Terlipressin-induced QT prolongation","volume":"43","author":"Sidhu","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.ejim.2017.10.016_bb0405","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0410","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jacc.2011.10.880","article-title":"Ursodeoxycholic acid in patients with chronic heart failure: a double blind, randomized, placebo-controlled, crossover trial","volume":"59","author":"von Haeling","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0415","first-page":"592","article-title":"Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejetion","volume":"17","author":"B\u00e4hrle","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ejim.2017.10.016_bb0420","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1111\/j.1572-0241.1999.01450.x","article-title":"A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis","volume":"94","author":"Baruch","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0425","first-page":"1229","article-title":"Conversion of cyclosporine A to tacrolimus following heart transplantation","volume":"15","author":"Mathieu","year":"1999","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0430","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.transproceed.2009.05.040","article-title":"Reversible myocardial hypertrophy induced by tacrolimus in a pediatric heart transplant recipient: case report","volume":"41","author":"Mano","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ejim.2017.10.016_bb0435","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0002-9149(98)00126-X","article-title":"Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation","volume":"81","author":"Chang","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0440","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.transproceed.2010.05.170","article-title":"Introduction of mycophenolate mofetil in maintenance liver transplant recipients: what can we expect? Results of a 10-year experience","volume":"42","author":"Dumortier","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ejim.2017.10.016_bb0445","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MOT.0b013e32834aa2e1","article-title":"De-novo calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolate mofetil after heart transplantation: 5-year results","volume":"16","author":"Meiser","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.ejim.2017.10.016_bb0450","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/TP.0000000000000965","article-title":"Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial","volume":"100","author":"Geissler","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2017.10.016_bb0455","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejim.2012.11.009","article-title":"Concomitant renal and hepatic dysfunctions in chronic heart failure: clinical implications and prognostic significance","volume":"24","author":"Poelzl","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0460","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2459\/JCM.0000000000000152","article-title":"Management of heart failure in the new era: the role of scores","volume":"17","author":"Mantegazza","year":"2016","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0465","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/eurheartj\/ehp032","article-title":"The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure","volume":"30","author":"Vazquez","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.10.016_bb0470","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/175925","article-title":"TNM-like classification: a new proposed method for heart failure staging","volume":"2013","author":"Fedele","year":"2013","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.ejim.2017.10.016_bb0475","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.sla.0000171327.29262.e0","article-title":"Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis","volume":"242","author":"Northup","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejim.2017.10.016_bb0480","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jhep.2005.01.019","article-title":"Evaluation of the increase in model for end-stage liver disease (DMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score","volume":"42","author":"Huo","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0485","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.transproceed.2016.01.079","article-title":"Predictive value of hepatic and renal dysfunction based on the models for end-stage liver disease in patients with heart failure evaluated for heart transplant","volume":"48","author":"Szygu\u0142a-Jurkiewicz","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ejim.2017.10.016_bb0490","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jacc.2012.12.056","article-title":"Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction","volume":"61","author":"Kim","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0495","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1253\/circj.CJ-15-1326","article-title":"Prognostic value of prothrombin time international normalized ratio in acute decompensated heart failure - a combined marker of hepatic insufficiency and Hemostatic abnormality","volume":"80","author":"Okada","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.ejim.2017.10.016_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100618","article-title":"Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure","volume":"9","author":"Abe","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2017.10.016_bb0505","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/ejhf.644","article-title":"Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure","volume":"18","author":"Biegus","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2017.10.016_bb0510","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/MEG.0000000000000817","article-title":"Acute circulatory failure-chronic liver failure-sequential organ failure assessment score: a novel scoring model for mortality risk prediction in critically ill cirrhotic patients with acute circulatory failure","volume":"29","author":"Zhou","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2017.10.016_bb0515","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.healun.2014.12.009","article-title":"Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction","volume":"34","author":"Farr","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ejim.2017.10.016_bb0520","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.healun.2012.02.008","article-title":"Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction","volume":"31","author":"Chokshi","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ejim.2017.10.016_bb0525","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.healun.2015.10.008","article-title":"Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: evidence from the registry of the United Network for Organ Sharing","volume":"35","author":"Deo","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ejim.2017.10.016_bb0530","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.athoracsur.2015.07.026","article-title":"MELD-XI score predicts early mortality in patients after heart transplantation","volume":"100","author":"Grimm","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejim.2017.10.016_bb0535","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/2048872615610865","article-title":"Baseline MELD-XI score and outcome from veno-arterial extracorporeal membrane oxygenation support for acute decompensated heart failure","volume":"5","author":"Sern Lim","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.ejim.2017.10.016_bb0540","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2459\/JCM.0b013e328352228e","article-title":"Gastrointestinal bleeding and coagulation disorders in a patient with left-ventricular assist device","volume":"14","author":"Correale","year":"2013","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.ejim.2017.10.016_bb0545","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.healun.2012.02.027","article-title":"Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system","volume":"31","author":"Yang","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ejim.2017.10.016_bb0550","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCULATIONAHA.108.838656","article-title":"Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality","volume":"121","author":"Matthews","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.10.016_bb0555","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10047-015-0853-x","article-title":"Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices","volume":"19","author":"Yost","year":"2016","journal-title":"J Artif Organs"},{"key":"10.1016\/j.ejim.2017.10.016_bb0560","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.athoracsur.2012.02.008","article-title":"Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy","volume":"93","author":"Bonde","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejim.2017.10.016_bb0565","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2017.10.016_bb0570","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2012.11.005","article-title":"Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes","volume":"61","author":"Metra","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517304247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517304247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:46:26Z","timestamp":1659746786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517304247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":114,"alternative-id":["S0953620517304247"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.10.016","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver disease and heart failure: Back and forth","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}